Fuso Pharmaceutical Industries,Ltd. (TYO:4538)
2,096.00
-1.00 (-0.05%)
Jul 4, 2025, 3:30 PM JST
TYO:4538 Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2013 | FY 2012 | FY 2011 | 2006 - 2010 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '13 Mar 31, 2013 | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | 2006 - 2010 |
Net Income | - | - | 6,237 | 6 | 984 | Upgrade
|
Depreciation & Amortization | - | - | 1,750 | 1,888 | 2,088 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | -2,472 | 26 | 86 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | 21 | - | 11 | Upgrade
|
Other Operating Activities | - | - | -14 | -30 | -37 | Upgrade
|
Change in Accounts Receivable | - | - | -3,170 | -401 | 2,019 | Upgrade
|
Change in Inventory | - | - | -901 | -881 | 984 | Upgrade
|
Change in Accounts Payable | - | - | 831 | 97 | -688 | Upgrade
|
Change in Other Net Operating Assets | - | - | 976 | 179 | 1,497 | Upgrade
|
Operating Cash Flow | - | - | 3,258 | 884 | 6,944 | Upgrade
|
Operating Cash Flow Growth | - | - | 268.55% | -87.27% | 217.66% | Upgrade
|
Capital Expenditures | - | - | -1,928 | -1,206 | -1,015 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | 3,975 | - | 9 | Upgrade
|
Investment in Securities | - | - | 635 | -105 | -218 | Upgrade
|
Other Investing Activities | - | - | -266 | -71 | -118 | Upgrade
|
Investing Cash Flow | - | - | 2,416 | -1,382 | -1,342 | Upgrade
|
Short-Term Debt Issued | - | - | - | 295 | - | Upgrade
|
Long-Term Debt Issued | - | - | 3,270 | 4,300 | 2,550 | Upgrade
|
Total Debt Issued | - | - | 3,270 | 4,595 | 2,550 | Upgrade
|
Short-Term Debt Repaid | - | - | -100 | - | -3,435 | Upgrade
|
Long-Term Debt Repaid | - | - | -3,452 | -3,104 | -3,355 | Upgrade
|
Total Debt Repaid | - | - | -3,552 | -3,104 | -6,790 | Upgrade
|
Net Debt Issued (Repaid) | - | - | -282 | 1,491 | -4,240 | Upgrade
|
Repurchase of Common Stock | - | - | -5 | -3 | -8 | Upgrade
|
Dividends Paid | - | - | -542 | -542 | -542 | Upgrade
|
Other Financing Activities | - | - | -3 | -3 | -2 | Upgrade
|
Financing Cash Flow | - | - | -832 | 943 | -4,792 | Upgrade
|
Foreign Exchange Rate Adjustments | - | - | - | -1 | -13 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | - | 1 | -2 | Upgrade
|
Net Cash Flow | - | - | 4,842 | 445 | 795 | Upgrade
|
Free Cash Flow | - | - | 1,330 | -322 | 5,929 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | 484.14% | Upgrade
|
Free Cash Flow Margin | - | - | 2.74% | -0.73% | 12.49% | Upgrade
|
Free Cash Flow Per Share | - | - | 146.90 | -35.56 | 654.59 | Upgrade
|
Cash Interest Paid | - | - | 261 | 247 | 302 | Upgrade
|
Cash Income Tax Paid | - | - | 17 | 44 | 48 | Upgrade
|
Levered Free Cash Flow | - | - | 1,161 | -313.13 | 5,546 | Upgrade
|
Unlevered Free Cash Flow | - | - | 1,326 | -149.38 | 5,737 | Upgrade
|
Change in Net Working Capital | 4,207 | - | 882 | 1,132 | -3,307 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.